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Abstract
Background: Loss of hand function is one of the most devastating consequences of spinal cord injury. Intensive
hand training provided on an instrumented exercise workstation in conjunction with functional electrical
stimulation may enhance neural recovery and hand function. The aim of this trial is to compare usual care with an
8-week program of intensive hand training and functional electrical stimulation.
Methods/design: A multicentre randomised controlled trial will be undertaken. Seventy-eight participants with
recent tetraplegia (C2 to T1 motor complete or incomplete) undergoing inpatient rehabilitation will be recruited
from seven spinal cord injury units in Australia and New Zealand and will be randomised to a control or
experimental group. Control participants will receive usual care. Experimental participants will receive usual care
and an 8-week program of intensive unilateral hand training using an instrumented exercise workstation and
functional electrical stimulation. Participants will drive the functional electrical stimulation of their target hands via
a behind-the-ear bluetooth device, which is sensitive to tooth clicks. The bluetooth device will enable the use of
various manipulanda to practice functional activities embedded within computer-based games and activities.
Training will be provided for one hour, 5 days per week, during the 8-week intervention period. The primary
outcome is the Action Research Arm Test. Secondary outcomes include measurements of strength, sensation,
function, quality of life and cost effectiveness. All outcomes will be taken at baseline, 8 weeks, 6 months and 12
months by assessors blinded to group allocation. Recruitment commenced in December 2009.
Discussion: The results of this trial will determine the effectiveness of an 8-week program of intensive hand
training with functional electrical stimulation.
Trial registration: NCT01086930 (12
th March 2010)
ACTRN12609000695202 (12
th August 2009)
Background
The incidence of spinal cord injury (SCI) varies between
countries but is estimated at 10 to 83 per million, per
year with most injured under the age of 25 years [1].
More than one third of these individuals sustain an
injury that causes damage to the spinal cord in the cer-
vical region and results in tetraplegia [1]. Most people
with tetraplegia remain wheelchair-dependent and reli-
ant on others for physical care. Importantly, however,
limited hand and upper limb function is often more
disabling and of greater importance to them than their
inability to walk [2,3]. Even modest improvements in
hand function can have life-changing implications. For
example, a small amount of finger movement enables a
person with tetraplegia to use a keyboard, press a
switch, scratch the face and turn the page of a book.
The ability to do these simple tasks reduces dependency
on others, improves potential for employment and
enhances quality of life.
There is evidence to suggest that intensive task-speci-
fic training can enhance hand function in people with
tetraplegia [4,5]. Intensive training with superimposed
functional electrical stimulation (FES) may be particu-
larly therapeutic especially in individuals with poor
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any medium, provided the original work is properly cited.grasp [6-8]. It is believed that this combination of thera-
pies provides the damaged spinal cord with excitation
from the sensorimotor cortex along with intensive sen-
sory input from the periphery. Neural bombardment of
this kind on the damaged spinal cord may promote
neural plasticity and, in particular, may provide the criti-
cal stimulus required to elicit neurophysiologic and
structural re-organisation of the relevant pathways [9].
Recent advances in computer-game technology pro-
vide innovative ways of encouraging patients to engage
in intensive task-specific training [10]. Here we describe
the protocol for a randomised controlled trial using FES
and an exercise workstation (ReJoyce, Rehabtronics Inc.
Edmonton, Canada). Patients wear a behind-the-ear blue
tooth sensor that is triggered by tooth clicks and sends
radio signals to a customised muscle-stimulator garment
worn on the forearm. This system enables people with
tetraplegia to independently stimulate their own hands
to open or close, allowing grasp and release of a variety
of manipulanda (pinch, squeeze, grasp, twist, lift, push,
pull; see Figure 1). The patients thus use their hands to
control the manipulanda and play computer games
while practising different hand grasps. The games are
graded according to hand function so even patients with
severe upper limb paralysis can participate and,
similarly, patients can play progressively more difficult
games as they improve. The technology thus provides a
way of encouraging patients to do large numbers of dif-
ferent hand movements within a dynamic environment.
The primary aim of this trial therefore is to determine
the effect on hand function of an intensive task-specific
hand training program provided with FES through an
instrumented exercise workstation. The secondary aim
is to determine possible benefits on muscle strength,
sensation, function, and quality of life.
Methods/Design
Funding
The trial is funded by theVictorian Neurotrauma Initiative,
NSW Lifetime Care and Support Authority, The University
of Melbourne and The University of Western Australia.
Design
A multi-centre randomised controlled trial will be
undertaken. One hand of each participant will be identi-
fied as the target hand. The target hand of participants
will be randomised to the experimental or control
group. Control participants will receive usual care while
experimental participants will receive usual care plus an
intensive 8-week program directed at the target hand.
The trial will be conducted through seven SCI units in
Australia and New Zealand. Ethical approval has been
obtained from the Human Research Ethics Committee
at each site and the University of Melbourne (HREC
0932764.1). Participants will be provided with informa-
tion sheets and written informed consent will be
obtained prior to recruitment and baseline assessment.
Subject recruitment commenced December 2009 and
will finish July 2011.
Participants
Seventy-eight participants with recently-acquired tetra-
plegia undergoing inpatient rehabilitation in one of the
seven participating SCI units will be recruited from a
consecutive sample of admissions (see Figure 2). Thera-
pists at each SCI unit will screen participants. One hand
of each participant will be identified as the target hand
according to the criteria below. In situations where both
hands meet the inclusion criteria, the hand deemed
most likely to benefit from intensive training by the
treating therapist will be selected.
Inclusion criteria
Participants will be included if they:
1. have sustained a SCI within the preceding
6 months
2. are currently receiving inpatient rehabilitation
through one of the seven participating SCI units
3. will remain in the SCI unit for 12 weeks as part of
standard rehabilitation
4. are 16 years of age or older and able to provide
informed consent
5. have a motor complete or incomplete SCI at the
neurological level of C2 to T1 (as per the International
Standards of Neurological Classification for SCI)
6. have reduced ability to grasp with the target hand
7. are able to tolerate sufficient FES to enable the
target hand to grasp and release
Figure 1 The instrumented exercise workstation (ReJoyce)
demonstrating the different manipulanda.
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Page 2 of 98. have the potential to benefit from the experimen-
tal intervention according to the judgment of the
treating therapist
Exclusion criteria
Participants will be excluded if they:
1. have any other type of neurological injury affect-
ing the target hand (e.g. brachial plexus or peripheral
nerve injuries)
2. have had trauma or surgery to the target hand or
upper limb within the last 12 months
3. have had amputation of any digits on the target
hand
4. are not able to sit out of bed for at least two
hours per day over three consecutive days
5. have extensive fixed contractures in the upper
limb of the target hand preventing use of the instru-
mented exercise workstation
6. have severe spasticity in the target hand or upper
limb preventing use of the instrumented exercise
workstation
7. are unable to attend the 6 month and 12 month
follow-up assessments
8. are likely to undergo hand surgery in the target
hand in the next year
9 .a r el i k e l yt oe x p e r i e n c ea u t o n o m i cd y s r e f l e x i ao r
hypotension in response to FES
10. have any contraindications to FES such as car-
diac pacemaker, epilepsy, forearm fracture or
pregnancy
11. have intracranial metal implants
12. have impaired vision or are unable to view a
computer screen
13. have any other serious medical condition likely
to influence cooperation and adherence to the proto-
col including malignancies and psychiatric, beha-
vioural or drug-dependency problems
Randomisation
Participants will be randomly assigned to either control
or experimental group with a 1:1 allocation as per a
computer generated randomisation schedule stratified
by site and the baseline score of the Action Arm
Research Test (ARAT; <= 21 versus >21) using per-
muted blocks of random sizes. The block sizes will not
be disclosed, to ensure concealment.
Prior to commencement of the trial, an independent
researcher with no clinical involvement in the trial will
use a computer random number generator to produce
the randomisation schedule. Randomisation will occur
after completion of baseline assessments by contacting
an administrator independent of the recruitment process
and located off site at Neuroscience Trials Australia, for
allocation assignment. A participant will be considered
to have entered the trial once his/her randomisation is
revealed.
Intervention
Control participants
Control participants will receive usual care and will not
receive any electrical stimulation to the target hand or
upper limb nor will they be exposed to the instrumented
exercise workstation.
Experimental participants
In addition to the usual care provided to all participants,
experimental participants will receive one hour of one-
to-one hand training directed at the target hand with a
research therapist, five times per week for 8 weeks. The
training will consist of an intensive task-specific hand
training program provided through an instrumented
exercise workstation (ReJoyce) in conjunction with FES.
The hand activities will involve playing computer games
while practising functional tasks (including reaching,
grasping, manipulating, pulling, rotating and releasing)
using different manipulanda (see Figure 1).
The exercises and computer games will be progressed
so that, as hand function improves, more difficult hand
exercises and games will be introduced. Each training
session will be one hour long and participants will be
required to use the instrumented exercise workstation
and FES as much as possible during this time.
The FES will be provided through 5 cm diameter elec-
trodes embedded in wetted cloth pads backed with
stainless steel mesh. The electrodes will be incorporated
Figure 2 Flow diagram of the trial.
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trode pair will be placed over the proximal end of each
target muscle. The reference electrode will be placed on
the dorsal surface of the forearm and just proximal to
the wrist joint. The FES will be provided in trains of sti-
muli (50 per second: 200 μs biphasic, current-controlled
pulses). The FES will be administered to any or all of
the muscles that facilitate opening or closing of the
hand including the flexors and extensors of the wrist,
fingers and thumb.
FES will be triggered by participants clicking their
teeth. The tooth clicks (vibrations) will be detected by a
wireless earpiece, similar to a hearing aid, which sends a
radio signal to the stimulator garment. This in turn sti-
mulates the hand to open or close, allowing participants
to grasp or release objects. The stimulator system has
been tested and approved by the Canadian Standards
Association. As it is not yet approved in Australia, the
stimulator is being used for this trial under the Clinical
Trials Notification Scheme of the Therapeutic Goods
Administration of Australia.
If participants miss any treatments during the 8-week
intervention period, the missed sessions will be offered to
participants on weekends or during an optional addi-
tional week at the end of the 8-week intervention period.
All participants
All participants will continue to receive usual care for the
hand and upper limb as typically provided by their SCI
units. Usual care will be individualised to the needs of
participants but will involve at least three 15-minute ses-
sions per week of one-to-one therapy specifically directed
at the target hand. This may consist of practising any or
all of the following functional activities: moving checkers,
grasping and releasing objects, manipulating objects,
turning keys, pouring water and opening jars. In addition,
all participants will receive any of the following as typi-
cally provided by participants’ usual treating therapists as
part of regular physiotherapy as well as vocational,
recreational and occupational therapy:
￿ strength training
￿ training for activities of daily living (e.g. training
for dressing, cooking or self care)
￿ computer-based games provided they only involve
a headset, mouse or keyboard
￿ training in writing and the use of keyboards
￿ computer training (e.g. training in the use of word
processors, internet or computer games)
￿ passive or assisted active movements (e.g. provided
by therapists, family, carers or devices)
￿ stretches (e.g. provided by therapists, family, carers
or devices)
￿ splinting (e.g. functional splints, resting splints,
active-assist splints or hand orthoses)
￿ pressure garments or bandaging for oedema man-
agement or for the promotion of a passive tenodesis
grip (e.g. JOBST gloves or pressure bandaging)
￿ arm ergometry
The use of computer games that involve hand and
upper limb movement, for example games associated
with Nintendo Wii
®, PlayStation
® or similar equipment,
will be limited where possible during the 8-week inter-
vention period. There will be no restrictions past the
8-week intervention period.
Follow-up period
At the end of the 8-week intervention period, both
experimental and control participants will continue to
receive usual care up until the 12-month follow-up
assessment. This may, or may not, involve sessions with
a therapist. Therapy will not be standardised or
restricted in any way. Instead, it will be left to the dis-
cretion of the treating therapists associated with the SCI
units and care providers following discharge. The only
restriction will be that neither experimental nor control
participants use the instrumented exercise workstation.
In addition, no participant will be permitted to practice
any aspect of the outcome measures. They may, how-
ever, practice activities similar to those included in the
hand tests as part of functional training.
Quality assurance
To ensure that the treatments are of a high standard
and are delivered in accordance with the trial protocol,
therapists responsible for administering the intensive
training to experimental participants will attend a two-
day workshop where they will be trained in the delivery
of the treatment program. They will also be provided
with a written protocol and standardised recording
documents. In addition, all treatments provided to both
experimental and control participants will be carefully
recorded. For example, the following variables will be
recorded during each treatment provided to experimen-
tal participants: therapy time, proportion of time spent
with the stimulation activated, difficulty of games played
and proportion of time spent playing games. Likewise
usual care provided to both control and experimental
participants will be recorded using a standardised form
(the Spinal Cord Injury-Interventions Classification
System) [11].
Outcome assessments
Measurements will occur at baseline, 8 weeks after the
commencement of the intervention period (8 weeks),
and then at 6 months and 12 months after randomisa-
tion (see Table 1). There is a 3-week period after ran-
domisation when all participants receive usual care
prior to the commencement of the 8-week interven-
t i o np e r i o d .T h i si st oa l l o wt i m ef o rt h ed e l i v e r yo f
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are custom made in Canada). For this reason, the 8-
week assessments are 8 weeks after commencement of
the intervention period but 11 weeks after
randomisation.
All assessments will be made by research therapists
blinded to group allocation. Any inadvertent unblinding
of assessors will be reported. In addition, the success of
blinding will be estimated by asking assessors to guess
participants’ group allocations at the completion of each
post-randomisation assessment.
Primary outcome
The primary outcome is the:
Modified Action Research Arm Test (ARAT) for the target
hand at 8 weeks
The ARAT is a standardised measure of unilateral hand
and upper limb function. It consists of four sub-tests
including grasp, grip, pinch and gross movement. Parti-
cipants will be required to perform every task in each
subtest [12]. All tasks will be scored on a 4-point scale
from 0 to 3 where 0 reflects poor hand function and 3
reflects good hand function. Scores will be summed to
give a total possible score of 57 where a larger number
reflects better hand function. The modified non-standar-
dised table height will be used and testing will be done
in a seated position. Although the ARAT was originally
used as a measure of arm and hand function after
stroke, [13] it has been successfully used in a trial simi-
lar to this one conducted in people with established SCI
[personal communication; Prochazka A, 2009]. The
ARAT has excellent reliability and has been validated
against a number of other upper limb function tests
[14-17]. It also has good face validity, assessing a range
of functional hand tasks.
Secondary outcomes
The secondary outcomes are the:
Modified Action Research Arm Test (ARAT) for the target
hand at 6 months and 12 months
The ARAT will be performed and scored as described
above.
Summed Upper Limb Strength of the target hand at 8
weeks, 6 months and 12 months
The strength component of the Graded and Redefined
Assessment of Strength, Sensibility and Prehension
(GRASSP) will be used to assess upper limb strength of
the target hand [18]. This consists of a 6-point manual
muscle test [19] to score the following nine joint
actions: shoulder flexion, elbow flexion, elbow extension,
wrist extension, finger flexion, finger extension, finger
abduction, thumb flexion, and thumb opposition. Scores
will be summed to give a total possible score of 65
where a higher score indicates better strength than a
lower score. Testing will be done in a seated position.
AIS Sensory Assessment of the target hand at 8 weeks, 6
months and 12 months
The AIS sensory assessment is part of the assessment
for the International Standard for Neurological Classifi-
cation of Spinal Cord Injury. It involves testing pin-
prick and light touch sensation at key points represent-
ing each cervical dermatome. Pin-prick and light-touch
sensation of each dermatome is separately scored on a
3-point scale. Scores will be summed to give a total pos-
sible score of 32 where a higher score indicates better
sensation than a lower score.
AsTex
® Sensory Test of the target hand at 8 weeks, 6
months and 12 months
The AsTex
® sensory test assesses the texture discrimina-
tion capabilities of the thumb and fingertips. It requires
participants to run their thumbs, index fingers and little
fingers along a grooved acrylic surface with logarithmi-
cally decreasing spaces and to stop when they perceive it
as smooth [20]. The mean texture discrimination index
(TDI) of the finger, thumb and little finger will be derived
from three trials for each digit. The results will be inter-
preted with respect to age-related normative values
where a lower score reflects better texture discrimination
than a higher score.
AuSpinal Assessment of the target hand at 8 weeks, 6
months and 12 months
The AuSpinal Hand Assessment is a unilateral measure
of hand function [21]. It consists of a number of hand-
related tasks using the following objects: a key, nut/bolt,
Table 1 Timeline of participants’ progression through the trial
week -3 week -1 week 0 weeks
0-3
weeks 4 - 12 week 13
† weeks
14 - 25
week 26
§ weeks
27 - 51
week 52
§
screening baseline
assessment
by blinded
assessor
concealed
random
allocation
usual care
for all
participants
€
8-week intervention Exp:
Instrumented exercise
workstation, FES and
usual care
Control: usual care
8-week
assessment
by blinded
assessor
usual care
for all
participants
6-month
assessment
by blinded
assessor
usual care
for all
participants
12-month
assessment
by blinded
assessor
† plus or minus 1-week window for commencement; 1-week window for completion upon commencement.
§ plus or minus 1-week window for commencement; 1-week window for completion upon commencement.
€ this 3-week period is to allow time for the ordering and delivery of the personalised FES garment for experimental participants.
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drink can. Scores will be summed to give a total possible
score of 86 where a higher score reflects better hand
function than a lower score.
The Goal Attainment Scale (GAS) of the target hand at 8
weeks
The GAS captures improvements on self-selected goals
[22-24]. Prior to baseline assessments, participants will
identify two personal goals related to use of their target
hands in conjunction with their treating therapists. The
goals will be set according to the SMART principle, that is,
the goals will be specific, measurable, attainable, realistic
and timely [25]. Participants will rate their perceptions of
attainment at the 8-week assessment with the assistance of
blinded assessors. The two goals will be rated on a 5-point
scale, where “0” denotes the expected level of achievement;
“+1” and “+2” are respectively “a little” and “al o t ” better
than expected, whilst “-1” and “-2” are correspondingly “a
little” and “al o t ” less than expected. The scores for the two
goals will be averaged with a higher score reflecting better
achievement of goals than a lower score.
The Capabilities of Upper Extremity (CUE) of the target
hand at 8 weeks, 6 months and 12 months
The CUE is an interview-based questionnaire about per-
ceptions of upper limb function specifically designed for
participants with tetraplegia. Fifteen questions of the
CUE related to unilateral hand and upper limb function
will be used. The questions address reaching and lifting,
pulling and pushing, wrist actions as well as hand and
finger actions. Participants will rate their abilities to per-
f o r mt h e1 5i t e m so nas e v e n - p o i n ts c a l ef r o m1t o7
[26]. Scores will be summed to give a total possible
score of 105 where a higher score reflects better upper
limb function than a lower score.
Assessment of Quality of Life - 8 (AQoL - 8) at 8 weeks, 6
months and 12 months
The AQoL-8 is a health-related quality of life instru-
ment [27,28]. It is a self-administered 8-item question-
naire that provides utility scores varying between -0.04
(worse than death), 0 (death) and 1 (perfect health)
where a higher score reflects better quality of life than a
lower score.
Health Utilities Index Mark 3 (HUI3) at 8 weeks, 6 months
and 12 months
The HUI3 is a self-administered questionnaire of
health-related quality of life [29]. It covers eight attri-
butes (vision, hearing, speech, ambulation, dexterity,
emotion, cognition and pain) with five or six levels for
each attribute. It is widely used in population health
surveys, clinical studies and cost-utility analyses. HUI3
discriminates various aspects of burden associated with
chronic conditions and describes the differences in
overall health-related quality of life levels. Like the
AQoL, it provides utility scores varying between -0.36
and 1 where a higher score reflects better quality of
life than a lower score.
The self-care subscale of the Spinal Cord Independence
Measure - Version III (SCIM) at 8 weeks, 6 months and 12
months
The SCIM was designed specifically for patients with
SCI. The SCIM focuses on the ability to perform basic
everyday tasks and takes into consideration the eco-
nomic burden of disability as well as the impact of dis-
ability on overall medical condition and comfort [30].
The self-care subscale consists of six items which
address ability to feed (score 0 to 3), bathe upper body
(scored 1 to 3), bathe lower body (scored 1 to 3), dress
upper body (scored 1 to 4), dress lower body (scored 1
to 4) and groom (scored 0 to 3). Scores will be summed
to give a total possible score of 20 where a higher score
reflects more independence than a lower score.
Participant Perception of Treatment Effectiveness at 8
weeks
Participants will be required to rate their perceptions
about changes in hand function on a 15-point scale
where zero indicates no change, +7 indicates “av e r y
great deal better” and -7 indicates “a very great deal
worse” [31].
Economic outcomes
Economic evaluation will determine whether the
experimental intervention is more cost-effective than
the control intervention. Cost-effectiveness analysis
will measure incremental costs in the two groups in
relation to the ARAT, health utility and quality of life
measures. The primary focus will be the health care
sector. All relevant costs associated with delivery of
experimental and control interventions will be used.
The cost of treatment will be estimated using standard
costs for therapy and actual costs of training equip-
ment expressed as a mean cost of treatment per parti-
cipant. Community-based resource use in the 12-
month follow-up period will include data on visits to
GPs, specialists or other health care providers, pharma-
ceutical costs, as well as data on resource use specifi-
cally relating to levels of independent functioning (e.g.
aids, equipment, community services, home help, home
maintenance, meals on wheels, transport, formal and
informal care).
Burden of the experimental interventions on participants
At the 8-week assessment, all participants will be asked
by the blinded assessors to rate on a 10- point category
rating scale their perceptions about the convenience or
inconvenience of the hand training received to the target
hand. This will be used to gauge the burden of the
experimental intervention on participants. It will not be
used as an outcome measure.
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Sample Size
A sample size of 78 (i.e. 39 per group) will be used based
on 80% power, a between-group minimally worthwhile
treatment effect on ARAT scores at 8 weeks of 5.7 points,
a two-sided hypothesis test, an alpha level of 5%, a stan-
dard deviation of 14 points [personal communication; Pro-
chazka A, 2009], an ANCOVA model that includes
baseline ARAT score as a covariate, a correlation between
baseline and 8 weeks ARAT scores of at least 0.8, and an
adjustment to allow for a drop-out rate of 10%. All data
are based on the results of a similar pilot study conducted
in Canada [personal communication; Prochazka A, 2009].
Stata software (Version IC 10, StataCorp, College Station,
TX) was used for sample size calculations.
Analysis
The primary analysis of ARAT score at 8 weeks will be
performed using an ANCOVA model that includes
treatment group and site as factors, and the baseline
ARAT score as a covariate. All secondary outcomes
(including the ARAT at 6 months and 12 months) will
be analysed using a mixed model repeated-measures
(MMRM) approach where applicable (i.e. where data are
collected at 8 weeks, 6 months and 12 months). Multi-
ple imputation analysis will be performed to account for
the effect of missing data.
Analyses will be performed by a blinded and indepen-
dent statistician according to the intention-to-treat prin-
ciple and using the full dataset comprising all
randomised participants. In addition, the primary analy-
sis on the 8 weeks ARAT data will be repeated using a
per protocol dataset. This dataset will only comprise
participants who adhered to all aspects of the protocol
and received at least 80% of training sessions (i.e., con-
trol participants who received at least 80% of the 15-
minute sessions of one-to-one hand therapy and experi-
mental participants who received this as well as 80% of
the training sessions with the instrumented exercise
workstation and FES). All analyses will be performed
using Stata (Version 11 or higher).
Data integrity and management
Data will be stored electronically on a database with
secured and restricted access. Data transfer will be
encrypted and any information capable of identifying
individuals removed.
Withdrawal
A participant will be considered to have withdrawn from
the trial when consent is revoked or if the participant
cannot be contacted or located. If this occurs, no further
assessments will be performed. Participants will not be
withdrawn from the trial for protocol violations.
Monitoring
The trial will be overseen and monitored by a program
manager. The program manager will visit each site to exam-
ine trial procedures, ensure data quality and monitor com-
pliance with the trial protocol. Three safety variables will be
monitored and documented throughout the trial. These are
self-reported pain (using an 11-point category rating scale),
blood pressure and skin irritation from the stimulating elec-
trodes. However, only two safety variables (pain and blood
pressure) are considered serious enough to warrant inclu-
sion in the safety interim analysis. This analysis will be
undertaken when 40 patients have completed the 8-week
assessment. It will be done by an Independent Data Safety
Monitoring Board comprising a statistician and two rehabi-
litation doctors. If there are concerns about the safety of
participants, this board will make a recommendation to the
trial steering committee about continuing, stopping, or
modifying the trial. The Haybittle-Peto procedure for gen-
erating early stopping boundaries will be used. A recom-
mendation of early termination due to experimental
treatment inferiority on pain (mean margin of 4/10) or
blood pressure (mean margin of 40 mmHg) will be consid-
ered by the Independent Data Safety Monitoring Board if
the corresponding Haybittle-Peto boundary (p = 0.003, Z =
3) at a given interim analysis is crossed. No formal interim
analyses for efficacy or futility are planned.
Discussion
This trial will provide information about the effective-
ness of an intensive task-specific hand training program
provided with FES through an instrumented exercise
workstation. Hand function in people with tetraplegia is
central to their quality of life. Any treatment that can
improve their hand function has the potential to make
real and important differences to the lives of those
affected by SCI.
This trial will adhere to key methodological princi-
ples important for minimising bias and will be
reported according to the CONSORT guidelines. For
example, allocation will be concealed and randomised,
assessors will be blinded and analyses will be per-
formed on an intention-to-treat basis. Therapists and
participants will not be blinded due to the nature of
the intervention.
O n ep r i m a r yo u t c o m ea n dan u m b e ro fs e c o n d a r y
outcomes will be used. The primary outcome reflects
unilateral hand function. The secondary outcomes
include measures of impairment, activity limitation and
participation restriction, and encompass both objective
measures as well as participants’ perceptions.
It is anticipated that this trial will take three years to
complete. Recruitment commenced in December 2009
with the first participant randomised in February 2010.
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follow up assessments will be completed in 2012.
Consent
Written informed consent was obtained from the patient
for publication of Figure 1. A copy of the written con-
sent is available for review by the Editor-in-Chief of this
journal.
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